NCT02271282View on ClinicalTrials.gov

Estradiol-Receptor Blockade in Older Men and Women

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Normal Healthy Volunteers

Interventions

DRUG

Toremifene

DRUG

Placebo

DRUG

GHRH/Ghrelin combined Injection

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT02271282 - Estradiol-Receptor Blockade in Older Men and Women | Biotech Hunter | Biotech Hunter